(NASDAQ: OSRH) Osr Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,640.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,452.58%.
Osr Holdings's revenue in 2025 is N/A.On average, 3 Wall Street analysts forecast OSRH's revenue for 2025 to be $89,521,012, with the lowest OSRH revenue forecast at $86,029,513, and the highest OSRH revenue forecast at $92,165,309.
In 2026, OSRH is forecast to generate $81,536,775 in revenue, with the lowest revenue forecast at $78,353,349 and the highest revenue forecast at $83,950,017.